Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC48H54Cl2N8O10 |
InChIKeyOHGOKRHLLKPKJK-UHFFFAOYSA-N |
CAS Registry1835705-40-2 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | United States | 23 Nov 2015 |





